Dr. Fuad Ibrahim Abaleka, MD

Dr. Abaleka practices at Howard University Hospital in Washington, District of Columbia, part of Howard University.

Dr. Abaleka's NPI, 1861925596, was assigned on April 10, 2017. Dr. Abaleka holds Texas license S7162.

Dr. Abaleka's primary practice is Howard University Hospital, at 2041 Georgia Ave NW, Washington, DC 20060 in The District County. The practice phone is (202) 745-6100.

Dr. Abaleka's primary practice is Howard University Hospital in Washington, District of Columbia, part of Howard University. Dr. Abaleka is also affiliated with Adventist HealthCare White Oak Medical Center. The medical group on file is US Acute Care Solutions (USACS). Dmand AI also links Dr. Abaleka to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abaleka practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Abaleka's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Abaleka is licensed in Texas.

CMS data shows 780 Medicare services from Dr. Abaleka across 5 procedure codes in 2024, for 238 Medicare patients. Medicare paid $66,583 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 238 Medicare patients who saw Dr. Abaleka in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abaleka's median patient age at 70, with 55% women.

In 2024, Dr. Abaleka wrote 209 Medicare Part D claims for 98 patients. 86% of them were for generic drugs. CMS names the drug for 55 of them, across 3 drugs with 11 or more claims each, at $262 in total drug cost. In 2023, CMS named 279 claims across 12 drugs.

Dr. Abaleka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Abaleka, published from 2020 to 2024. 2020 was the busiest year, with 5. Dr. Abaleka has published most often in Cureus. Dr. Abaleka's most frequent co-authors are Bisrat Mogus Nigussie, MD, Genanew Bedanie, MD and Maham Suhail, DO.

CMS Open Payments shows 5 general payments to Dr. Abaleka from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $62.